Literature DB >> 31192829

A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis.

Justin Tan1, Paul Yong1,2, Mohamed A Bedaiwy1,2.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to summarize and highlight recent critical advances in the diagnosis, classification, and management of adenomyosis. RECENT
FINDINGS: Recent studies have clarified the specific mechanism through which adenomyotic lesions invade the underlying myometrium by epithelial-mesenchymal transition. Correlation studies using diagnostic MRI also strongly support the hypothesis of a different pathogenesis between the inner and outer myometrium forms of adenomyosis. Given advances in diagnostic imaging, several international organizations have also highlighted the importance of classification systems for adenomyosis. Finally, selective progesterone receptor modulators and gonadotropin-releasing hormone antagonists have demonstrated significant promise for treating pelvic pain and bleeding associated with adenomyosis, whereas novel fertility-preserving surgical techniques have been introduced to excise diffuse adenomyotic pathology while maintaining adequate uterine integrity.
SUMMARY: Recent attempts at a uniform and reproducible classification system likely represent the first step for the development of a staging system for adenomyosis that can be correlated with the severity of clinical symptoms and promote an individualized therapeutic approach. Simultaneously, further insights into the etiology and pathogenesis as outlined in this review may also help in the development of targeted medical therapies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31192829     DOI: 10.1097/GCO.0000000000000555

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  8 in total

1.  SWI/SNF inactivation in the endometrial epithelium leads to loss of epithelial integrity.

Authors:  Jake J Reske; Mike R Wilson; Jeanne Holladay; Marc Wegener; Marie Adams; Ronald L Chandler
Journal:  Hum Mol Genet       Date:  2020-12-18       Impact factor: 6.150

2.  Estrogen-increased SGK1 Promotes Endometrial Stromal Cell Invasion in Adenomyosis by Regulating with LPAR2.

Authors:  Guangzheng Zhong; Qingxue Zhang; Yingchen Wu; Hao Wang; Yi Li; Yangzhi Li; Yihua Liang
Journal:  Reprod Sci       Date:  2022-07-07       Impact factor: 2.924

3.  Giant exophytic cystic adenomyosis with a levonorgestrel containing intrauterine device out of the uterine cavity after uterine myomectomy: A case report.

Authors:  Yong Zhou; Zheng-Yun Chen; Xin-Mei Zhang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

4.  Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-05-14       Impact factor: 5.211

5.  Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study.

Authors:  Shuyi Chen; Jianzhang Wang; Wenting Sun; Libo Zhu; Jiayi He; Xinmei Zhang
Journal:  Ann Transl Med       Date:  2020-11

6.  Adenomyotic cyst mimicking a congenital Müllerian anomaly: Diagnosis and treatment with laparoscopy.

Authors:  Sangam Jha
Journal:  Clin Exp Reprod Med       Date:  2021-01-20

Review 7.  Classifying Adenomyosis: Progress and Challenges.

Authors:  Marwan Habiba; Giuseppe Benagiano
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

8.  Ultrasound-Guided Transvaginal Aspiration and Sclerotherapy for Uterine Cystic Adenomyosis: Case Report and Literature Review.

Authors:  Xinxin Zhao; Ye Yang
Journal:  Front Med (Lausanne)       Date:  2022-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.